Hj Hong

HJ Hong is a renowned investor and advisor with a focus on enterprise software, fintech, energy, and deep tech sectors. Currently serving as a Strategic Advisor at EarnDLT, an Investor at Romulus Capital, and the Chief of Tetrodotoxin Antitumoral Research at Seoul National University of Science and Technology, HJ Hong has established a diverse and successful career in the investment and research domains.

HJ Hong's educational background includes a Bachelor's degree in Biology & Business Management from Columbia University, along with further studies in Business Management at Columbia Business School. Their academic prowess combined with practical experience equips them with a well-rounded approach to their work.

Over the years, HJ Hong has held key positions in various organizations, including serving as the Chief of Staff at EarnDLT, an Investor at Takeoff Capital, Soil Connect, Flex, Finless Foods, ROKIT Healthcare, Inc., and Romulus Capital. Additionally, they have experience in Capital Markets at Bridge Investment Group and have been involved in academic initiatives like the Columbia Chapter Co-Founder at Scholars of Finance.

Furthermore, HJ Hong's professional journey includes research roles at Columbia University Irving Medical Center and Seoul National University of Science and Technology, showcasing a strong blend of academic research and practical investment experience. Their involvement as an Angel Investor reflects a keen interest in supporting up-and-coming ventures in various industries.